Target intelligence / Profile preview

Voltage-dependent anion-selective channel protein 1 (VDAC1)

Target
VDAC1
Molecular classification
Ion channel, β-barrel transmembrane pore protein, Mitochondrial porin
01

Overview

Voltage-dependent anion-selective channel protein 1 (VDAC1) is a β-barrel ion channel located in the outer mitochondrial membrane, ubiquitously expressed across eukaryotic cells[1][2][3][4][6]. It is the primary gateway for the movement of small hydrophilic molecules, nucleotides, and ions (such as ATP, ADP, Ca^2+^) between the mitochondria and cytosol, directly linking mitochondrial energetics to cytoplasmic metabolic demand[1][2][4]. VDAC1’s conformational state is voltage-dependent, alternating between open (anion-selective, high conductance) and closed (cation-selective, low conductance) forms[1][2][3][5]. Functionally, VDAC1 interacts with metabolic enzymes (such as hexokinase) and apoptosis-regulating proteins (such as Bcl-2 family members), acting as a central regulator of cell life and death, including the release of apoptotic factors like cytochrome c[4][6]. Dysregulation of VDAC1 is implicated in many diseases, including cancer (where it is often overexpressed), neurodegenerative disorders, diabetes, and cardiovascular disease[2][4][6]. As such, VDAC1 is considered a highly promising therapeutic target with ongoing drug development focused on modulating its function for cancer and other disorders[6].

Other names
Non-selective voltage-gated ion channel VDAC1VDACVDAC-1hVDAC1PORINOuter mitochondrial membrane protein porin 1Plasmalemmal porinPorin 31HLPorin 31HMSperm binding protein 1a
02

Mechanism of action

Blocking or modulating VDAC1 affects mitochondrial permeability and apoptosis. Disruption of interaction with Bcl-2 family proteins or hexokinase promotes apoptosis in cancer cells. Modulation of Ca^2+^ and ATP flux through outer mitochondrial membrane.

03

Biological functions

Transport of ATP, ADP, and other metabolites between mitochondria and cytosolRegulation of cell metabolism and energeticsGatekeeping for ions (including Ca^2+^), nucleotides, and metabolitesRegulation of apoptosis via release of cytochrome c and other apoptotic factorsScaffold for regulation of metabolic enzymes (e.g., hexokinase)Ca^2+^ homeostasis
04

Disease associations

Cancer (overexpression linked to tumor growth and apoptosis evasion)Neurodegenerative diseases (Parkinson's, Alzheimer's)Type 2 Diabetes (overexpression associated with disease progression)Cardiovascular diseaseAging and oxidative stress
05

Safety considerations

Potential for excessive apoptosis or cell death if VDAC1 is overly inhibitedMitochondrial dysfunction and impaired metabolism as possible adverse outcomesOff-target effects due to VDAC1’s broad role in multiple tissues
06

Interacting drugs

VDAC1 inhibitors and modulators under investigation (no approved drugs directly targeting VDAC1 yet)

1 more in the full profile.

07

Biomarkers

Overexpression of VDAC1 in cancer tissue can serve as a biomarker of malignancy and poor prognosisElevated VDAC1 levels linked to beta cell dysfunction in diabetesMitochondrial permeability transition and cytochrome c release (used in apoptosis assays)

Beyond the preview

Go deeper on Voltage-dependent anion-selective channel protein 1 (VDAC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voltage-dependent anion-selective channel protein 1 (VDAC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call